Manisha Bhutani MD

Hematologic Oncology

Physician

1021 Morehead Medical DrSte ACharlotte, NC 28204
Phone+1 980-442-2000
Fax+1 704-355-5800

Dr. Bhutani is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhutani's full profile Already have an account?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 2008 - 2011
Pt. B.D. Sharma Postgrad Institute of Medical ScienceClass of 1990

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NC State Medical License 2014 - 2027
MI State Medical License 2008 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.
Efstathios Kastritis, Giovanni Palladini, Monique C Minnema, Ashutosh D Wechalekar, Arnaud Jaccard
Blood. 2026-05-12
Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.
Shebli Atrash, James Symanowski, Myra Robinson, Cecilia Flynn, Sarah Norek
Blood Advances. 2026-05-12
1 citations
Performance evaluation of an automated mass spectrometry system for the measurement and isotyping of monoclonal immunoglobulins.
Jamie Ashby, Daniel McEntee, Dhananjay Sakrikar, Luke Ouverson, Rhiannon Stanton
Clinica Chimica Acta; International Journal of Clinical Chemistry. 2026-04-15

Lectures

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific AssemblyAugust 15th, 2024
To Focus on Hematologic Malignancies in Upcoming State of the Science SummitApril 18th, 2018
® to Host State of the Science Summit™: Diagnosis, Management and Treatment of Multiple MyelomaMay 17th, 2017